Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques.

[1]  J. Afilalo,et al.  Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. , 2010, American heart journal.

[2]  E. Romagnoli,et al.  Comparison of the Long-Term Safety and Efficacy of Drug-Eluting and Bare-Metal Stent Implantation in Saphenous Vein Grafts , 2010, Circulation. Cardiovascular interventions.

[3]  E. Mahmud,et al.  Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention. , 2010, The American journal of cardiology.

[4]  C. Lau,et al.  Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study. , 2010, Journal of interventional cardiology.

[5]  Deepak L. Bhatt,et al.  Drug-eluting versus bare-metal stents for treating saphenous vein grafts. , 2009, American heart journal.

[6]  Pierfrancesco Agostoni,et al.  Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. , 2007, Journal of the American College of Cardiology.

[7]  P. Serruys,et al.  Chronic total occlusion treatment in post‐CABG patients: Saphenous vein graft versus native vessel recanalization—Long‐term follow‐up in the drug‐eluting stent era , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[9]  N. Bruining,et al.  Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. , 2006, Journal of the American College of Cardiology.

[10]  G. Stone,et al.  Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial. , 2006, American heart journal.

[11]  Joseph P Ornato,et al.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[12]  A. Shah,et al.  Drug‐eluting stenting is superior to bare metal stenting in saphenous vein grafts , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  Patrick W Serruys,et al.  Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002. , 2005, European heart journal.

[14]  J. Popma,et al.  Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice , 2005, Circulation.

[15]  I. Iakovou,et al.  Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. , 2005, Journal of the American College of Cardiology.

[16]  Patrick W Serruys,et al.  Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. , 2004, Journal of the American College of Cardiology.

[17]  G. Stone,et al.  Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts , 2003, Circulation.

[18]  P. Feyter.  Percutaneous Treatment of Saphenous Vein Bypass Graft Obstructions A Continuing Obstinate Problem , 2003 .

[19]  G. Stone,et al.  Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts. , 2002, The American journal of cardiology.

[20]  M. Leon,et al.  Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts , 2002, Circulation.

[21]  B. Rutherford,et al.  Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. , 2001, Indian heart journal.

[22]  H. Nonogi,et al.  Percutaneous transluminal coronary angioplasty of chronic total occlusions. determinants of primary success and long‐term clinical outcome , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[23]  G. Stone,et al.  Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. , 1999, Circulation.

[24]  M. Bell,et al.  Influence of procedural success on immediate and long-term clinical outcome of patients undergoing percutaneous revascularization of occluded coronary artery bypass vein grafts. , 1996, Journal of the American College of Cardiology.

[25]  P. Serruys,et al.  Long-term clinical outcome after stent implantation in saphenous vein grafts. , 1996, Journal of the American College of Cardiology.

[26]  W. O’Neill,et al.  Features and outcome of no-reflow after percutaneous coronary intervention. , 1995, The American journal of cardiology.

[27]  B. Rutherford,et al.  Initial and long-term outcome of 83 patients after balloon angioplasty of totally occluded bypass grafts. , 1994, Journal of the American College of Cardiology.

[28]  W. Weintraub,et al.  Percutaneous Transluminal Coronary Angioplasty of Chronic Total Occlusions: Primary Success, Restenosis, and Long‐term Clinical Follow‐up , 1992, Circulation.

[29]  B Meier,et al.  Angiographic follow-up after placement of a self-expanding coronary-artery stent. , 1991, The New England journal of medicine.

[30]  J. Matloff,et al.  Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: ten years' experience. , 1987, American heart journal.

[31]  J. Ornato,et al.  ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention , 2006, Circulation.

[32]  W. O’Neill,et al.  Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial. , 1996, Journal of the American College of Cardiology.